![](/img/cover-not-exists.png)
334 HC07 ANRS trial - pilot study of triple therapy by recombinant interferona2A- ribavirin- IL-2 for treatment of nonresponder patients with severe liver disease infected by hepatitis C virus (HCV) genotype 1
Laurent L. Alric, Jacques Izopet, Sophie Metivier, Jean Tkaczuck, Bernard Pipy, Jean-Pierre VinelVolume:
38
Year:
2003
Language:
english
DOI:
10.1016/s0270-9139(03)80377-4
File:
PDF, 102 KB
english, 2003